He & She MD vs BreezeMeds: pricing, coaching, delivery compared
Quick verdict: He & She MD vs BreezeMeds shows He & She MD emphasizes bundled coaching, 1:1 clinician messaging, and lower introductory semaglutide injection pricing, while BreezeMeds highlights multiple injectable and oral GLP-1 options with discreet shipping and starting prices that begin at $199/month.
See He & She MD plans and app features
How they differ: Price structure and introductory rates
He & She MD lists compounded semaglutide injections starting at $139/month as a six-month introductory rate, with oral semaglutide and tirzepatide injections starting at $199/month for the first six months. The vendor notes those are promo prices that renew higher after the six-month term. BreezeMeds shows semaglutide injection starting at $199/month, tirzepatide injections starting at $299, and oral options displayed from $399; a separate $169 figure appears on BreezeMeds without a clear product association. Treatment availability and exact billing commitments for BreezeMeds were not fully visible in the captured evidence.
Practical takeaway
If introductory price for injectable semaglutide matters, He & She MD provides a clearly stated six-month promo starting at $139/month. BreezeMeds documents higher starting figures and an unclear $169 note that is not tied to a specific product in the captured evidence.
Coaching, clinician access, and program support
He & She MD bundles a coaching app with 1:1 clinician messaging, GLP-1 coaching, and progress tracking at no extra cost as part of its plans. BreezeMeds lists online intake and a personalized treatment plan and notes discreet home delivery and ongoing support, but the captured evidence does not show bundled 1:1 clinician messaging or an app included with price the way He & She MD does.
Check BreezeMeds eligibility and intake
Medication formats and regulatory notes
Both vendors offer injectable semaglutide and tirzepatide plus oral GLP-1 options. He & She MD specifies semaglutide injection, oral semaglutide, and tirzepatide injection. BreezeMeds lists injectable and oral semaglutide and tirzepatide. Both sources caution about compounded medication regulatory status: He & She MD explicitly states medications included in the GLP-1 Program are produced in USP-compliant, state-regulated pharmacies but are not reviewed by the FDA for safety, efficacy, or quality. BreezeMeds captured evidence says medication-specific approval status must be confirmed and that branded and compounded products are not interchangeable.
Transparency on billing terms and shipping
He & She MD provides explicit detail that promotional rates apply for the first six months and that plans renew at higher six-month prices; it also notes free expedited shipping and no membership fee. BreezeMeds markets discreet home delivery and starting prices but the captured evidence did not fully display fees, renewal terms, or clear billing commitments.
View He & She MD shipping and renewal details
Who each provider is best for
He & She MD is described as best for patients who want coaching and clinician access built into a plan and who have previously tried a bare-bones GLP-1 subscription without accountability. BreezeMeds is described as best for people who confirm eligibility, medication, total cost, renewal terms and state availability before enrollment.
| Criteria | He & She MD | BreezeMeds |
|---|---|---|
| Starting semaglutide injection price | $139/mo intro (six-month rate) | $199/mo starting |
| Tirzepatide pricing shown | $199/mo intro for injections (promo) | Starting at $299 for injections |
| Oral GLP-1 options | Oral semaglutide offered; oral pricing shown from $199 promo | Oral semaglutide and tirzepatide displayed from $399 |
| Coaching and clinician access | App with 1:1 clinician messaging and GLP-1 coaching included | Personalized treatment plan and online intake; bundled 1:1 messaging not shown |
| Shipping and membership | Free expedited shipping; no membership fee | Discreet shipping to your door; fees and membership details not fully visible |
| Regulatory notes | Compounded medications not reviewed by FDA; produced in USP-compliant pharmacies per vendor | Approval status must be confirmed; compounding status requires confirmation |
Start He & She MD eligibility check
Final comparison and recommendation
Across He & She MD vs BreezeMeds, He & She MD emphasizes bundled coaching, explicit six-month promotional pricing beginning at $139/month for semaglutide injection, and free expedited shipping. BreezeMeds documents a broader set of listed starting prices including $199/month for semaglutide injection and higher listed prices for oral products, and highlights discreet home delivery and an online intake. Both require clinician review to determine medical appropriateness and both signal that medication approval or compounding status should be confirmed.
Choose He & She MD if you want lower introductory semaglutide injection pricing plus a coaching app with 1:1 clinician messaging and built-in progress tracking.
Choose BreezeMeds if you prefer a provider that emphasizes discreet delivery and a personalized treatment plan but you will confirm eligibility, total cost, renewal terms, and state availability before enrolling.